Marriott International Inc vs McKesson Corporation — how do they compare? Marriott International Inc trades at $365 (market cap $96.76B), while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: Marriott International Inc and McKesson Corporation are close in size by market cap, and Marriott International Inc pays the higher dividend (0.8%). Which is the better fit depends on your goals.
| MAR | MCK | |
|---|---|---|
Market Cap | $96.76B | $97.35B |
Sector | Consumer Cyclical | Health |
52-Week High | $402.54 | $995.69 |
52-Week Low | $255.35 | $659.01 |
Enterprise Value | $113.71B | $101.98B |
Dividend Yield | 0.8% | 0.39% |
Signals from Pluang's Aura AI — not financial advice
Marriott International (MAR) trades at $367.81, up 0.43% on the day, with a bearish technical signal and mixed earnings history. The company reported 2025 revenue of $26.19B and net income of $2.60B, with a P/E of 38.42 and P/B of 443.63 indicating high valuation. Recent news includes strategic partnerships and the upcoming Q2 2026 earnings report on August 3, 2026.
The outlook is cautious due to high valuation and bearish technicals, but analyst consensus suggests a 5.6% upside to the $388.33 price target. Risks include rising debt-to-asset ratio (58.83% in 2025) and competitive pressures, while opportunities lie in travel demand growth and loyalty program strength.
No Aura AI signal available yet.
Trailing returns across standard periods
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →